微生物菌种改良筛选新技术研究进展

从自然界筛选出来的微生物菌株往往活性比较低,耐受性比较差,不能满足工业化生产的要求.而采用新颖的诱变技术,如微波、离子注入、原生质体诱变和原生质体融合、基因工程技术等能有效改良菌种,提高菌种的活性,降低生产成本,满足工业化生产的要求.同时,构建一种简单易行的改良路线和快速有效的筛选模式是菌种改良选育的关键.     

工业微生物菌种改造的新方法——优势小基因组生产菌的构建

本文介绍了构建优势小基因组生产菌株的必要性和可行性;介绍了优势小基因组工业微生物的构建原理和方法;同时,还介绍了几个目前已成功应用的通过基因组精简提高生产效率的例证;最后,结合作者的研究对优势小基因组生产菌的应用进行了展望。     

工业微生物菌种改造的新方法———优势小基因组生产菌的构建

摘要:本文介绍了构建优势小基因组生产菌株的必要性和可行性;介绍了优势小基因组工业微生物的构建原理和方法;同时,还介绍了几个目前已成功应用的通过基因组精简提高生产效率的例证;最后,结合作者的研究对优势小基因组生产菌的应用进行了展望。     

基于代谢网络预测菌种基因改造靶点方法的研究进展

高产特定产品的人工细胞工厂的构建需要对野生菌株进行大量的基因工程改造,近年来随着大量基因组尺度代谢网络模型的构建,人们提出了多种基于代谢网络分析预测基因改造靶点以使某一目标化合物合成最优的方法。这些方法利用基因组尺度代谢网络模型中的反应计量关系约束和反应不可逆性约束等,通过约束优化的方法预测可使产物合成最大化的改造靶点,避免了传统的通过相关途径的直观分析确定靶点的方法的局限性和主观性,为细胞工厂的理性设计提供了新的思路。以下结合作者的实际研究经验,对这些菌种优化方法的原理、优缺点及适用性等进行详细介绍,并讨论了目前存在的主要问题和未来的研究方向,为人们针对不同目标产品选择合适的方法及预测结果的可靠性评估提供了指导。     

有关微生物菌种选育技术的探索

所谓微生物菌种选育技术指的是,有机运用以遗传学为代表的相关原理,对目标微生物菌种展开相应筛选及其改造,从而达成所需产物大幅增产的一门技术。鉴于此,本文首先对传统微生物菌种选育技术进行了简要介绍,然后针对基因组改组技术进行了重点讨论和研究,以便同行参考。     

丝状真菌次级代谢产物生物合成的表观遗传调控

丝状真菌产生的次级代谢产物是新药的重要来源之一,其生物合成过程受到众多因素的调控。最近的研究表明,表观遗传对多种丝状真菌次级代谢产物的生物合成具有调控作用。DNA和组蛋白的甲基化与乙酰化修饰是目前所知的丝状真菌主要的表观遗传调控形式。通过过表达或缺失相关表观修饰基因和利用小分子表观遗传试剂改变丝状真菌染色体的修饰形式,不仅可以提高多种已知次级代谢产物产量,而且可以通过激活沉默的生物合成基因簇诱导丝状真菌产生新的未知代谢产物。丝状真菌表观遗传学正逐渐成为真菌菌株改良的新策略以及挖掘真菌次级代谢产物合成潜力的强有力手段。     

微生物菌种选育中的基因组改组技术及其应用进展

该文论述了基因组改组技术的产生和原理、方法和特点,以及该技术的应用、意义及其发展前景.基因组改组技术是首先对微生物菌株进行诱变,筛选出正向突变的菌株,然后通过原生质体"递推式融合"使这些正向突变的若干个菌株进行基因组重组,从中筛选出符合育种要求的重组子,从而在短时间内获得性状得到大幅度提高的菌株.     

肠道微生物组与宿主的表观遗传修饰

高通量测序技术已经增加了人们对肠道微生物组和表观遗传学修饰的理解,将肠道微生物组和宿主表观遗传学修饰紧密联系起来,阐明了很多疾病的发生过程如免疫、代谢、心血管疾病甚至是癌症。肠道微生物组与宿主具有相互作用,与人体密不可分,相辅相成。肠道微生物组的生态失调可能诱导疾病的发生并能调控宿主表观遗传学修饰。宿主表观遗传学调控和肠道微生物组(或其代谢产物)变化的相互关系在很多疾病中都有报道。因此,肠道微生物组可作为某些疾病的诊断标记,健康肠道微生物组的移植会逆转这种微生态失调,可作为一种有效的治疗策略。本文主要探讨了肠道微生物组直接调控宿主表观修饰和通过小分子生物活性物质和其他酶辅因子间接影响表观修饰,以及基于肠道微生物组调控宿主表观修饰的诊断和治疗应用等。     

“神七”搭载清华研制的工业用微生物菌种

在“神舟七号”搭载物品中,有清华研制的工业用微生物菌种．10月1日．在北京航天城举行的“神七”搭载物品交接仪式上．清华大学副校长陈旭亲手从中国航天五院党委书记．副院长李开民手中接过了这批珍贵的太空菌种并发表讲话．对“神舟七号”圆满成功表示祝贺．对所有为之付出努力的参研单位表示感谢．并表示将倍加珍惜这些菌种．并做好后续研究工作,为空间生物技术的发展贡献一份力量。     

酵母模式生物研究表观遗传调控基因组稳定性的进展

基因组的遗传稳定性是维持正常的细胞复制、增殖和分化的关键。外源因素和内源因素造成的DNA损伤及其修复失败, 是各种遗传疾病发生的根本原因。表观遗传调控(包括DNA甲基化、组蛋白修饰和非编码RNA)在DNA损伤修复和细胞周期调控方面发挥着重要的作用, 也是维持基因组稳定性的基础。酵母作为单细胞真核生物, 是最早开展表观遗传学研究的物种之一, 特别是在DNA损伤修复和异染色质形成等方面的研究, 为揭示遗传稳定性的本质提供了理论依据。国际上前期以酵母为模式生物研究表观遗传学的报道主要集中于组蛋白修饰领域; 近期利用裂殖酵母作为模式生物研究RNAi指导的组蛋白修饰也有了一定的进展。文章以酵母作为模式生物, 论述了表观遗传修饰在维持基因组遗传稳定性中的研究进展、作用机制和今后的发展趋势。     

系统生物学和合成生物学研究在生物燃料生产菌株改造中的应用

基于生物质资源生产环境友好的生物燃料,对经济和社会的可持续发展具有重要意义,但其生产成本高的问题十分突出,而高效生产菌株的获得是解决这一问题的根本出路。以下综述了利用系统生物学研究所获得的信息进行菌种改造的过程,重点论述了生产菌株胁迫耐受性方面的研究进展,并讨论了系统生物学、合成生物学和代谢工程技术在改造生物燃料生产菌株中的应用,展望了合成生物学在构建高效生物能源生产菌株方面应用的前景。     

Bioproduction of fumaric acid: an insight into microbial strain improvement strategies

Fumaric acid (FA), a metabolic intermediate, has been identified as an important carbohydrate derived platform chemical. Currently, it is commercially sourced from petrochemicals by chemical conversion. The shift to biochemical synthesis has become essential for sustainable development and for the transition to a biobased economy from a petroleum-based economy. The main limitation is that the concentrations of FA achieved during bioproduction are lower than that from a chemical process. Moreover, the high cost associated with bioproduction necessitates a higher yield to improve the feasibility of the process. To this effect, genetic modification of microorganism can be considered as an important tool to improve FA yield. This review discusses various genetic modifications strategies that have been studied in order to improve FA production. These strategies include the development of recombinant strains of Rhizopus oryzae, Escherichia coli, Saccharomyces cerevisiae, and Torulopsis glabrata as well as their mutants. The transformed strains were able to accumulate fumaric acid at a higher concentration than the corresponding wild strains but the fumaric acid titers obtained were lower than that reported with native fumaric acid producing R. oryzae strains. Moreover, one plausible adoption of gene editing tools, such as Agrobacterium-mediated transformation (AMT), CRISPR CAS-9 and RNA interference (RNAi) mediated knockout and silencing, have been proposed in order to improve fumaric acid yield. Additionally, the introduction of the glyoxylate pathway in R. oryzae to improve fumaric acid yield as well as the biosynthesis of fumarate esters have been proposed to improve the economic feasibility of the bioprocess. The adoption of some of these genetic engineering strategies may be essential to enable the development of a feasible bioproduction process.     

Genome shuffling: Progress and applications for phenotype improvement

Although rational method and global technique have been successfully applied in strain improvement respectively, the demand for engineering complex phenotypes required combinatorial approach. The technology of genome shuffling has been presented as a novel whole genome engineering approach for the rapid improvement of cellular phenotypes. This approach using recursive protoplast fusion with multi-parental strains offers the advantage of recombination throughout the entire genome without the necessity for genome sequence data or network information. Genome shuffling has been demonstrated as an effective method, which is not only for producing improved strain but also for providing information on complex phenotype. In this review we attempt to present the advantage of genome shuffling, introduce the procedure of this technology, summarize the applications of this approach for phenotype improvement and then give perspective on the development of this method in the future.     

代谢工程：一项不断发展的菌株改造技术

对代谢工程的发展进行了简要回顾,分析了代谢工程发展的推动力,重点评述了本期专栏发表的12篇代谢工程和细胞工厂方面的论文。     

Plant biotechnology for crop improvement

The typical crop improvement cycle takes 10–15 years to complete and includes germplasm manipulations, genotype selection and stabilization, variety testing, variety increase, proprietary protection and crop production stages. Plant tissue culture and genetic engineering procedures that form the basis of plant biotechnology can contribute to most of these crop improvement stages. This review provides an overview of the opportunities presented by the integration of plant biotechnology into plant improvement efforts and raises some of the societal issues that need to be considered in their application.     

以生物合成为基础的红霉素A的产量提高和结构改造

红霉素A是一种广谱大环内酯类抗生素,在临床上应用广泛。其生物合成包括由聚酮合酶催化的十四元环骨架形成,以及羟基化、糖基化、甲基化后修饰。基于对红霉素A生物合成机制的认识,可以对产生菌种进行定向的遗传操作,达到产量提高和结构改造等目的。本文综述了近年来在红霉素A高产菌株改造和化学结构衍生方面所取得的研究进展,为相关研究人员提供参考。     

Biotechnological production of feed nucleotides by microbial strain improvement

Sodium salts of inosine monophosphate (IMP) and guanosine monophosphate (GMP) are potent flavour enhancers. They are widely used as food additives in combination with monosodium glutamate (MSG) to synergistically increase umami flavour. In recent years, both inosine and guanosine derivatives have gained further importance because of their beneficial effects, related to their antioxidant, neuroprotective, cardiotonic and immunomodulatory properties. The industrial production of both IMP and GMP is mainly achieved either by RNA breakdown and nucleotide extraction or by microbial fermentation using different microorganisms such as Corynebacterium, Bacillus, or Escherichia coli. This work reviews the metabolic pathways and regulatory networks of purine synthesis, including both IMP and GMP, and the biotechnological processes applied to the production of these compounds, ranging from classical random mutagenesis to rational design by metabolic engineering. Recent advances of systems biology approaches, along with the rapid development of synthetic biology, may offer a basis for future manipulations to further increase the productivity of the fermentation processes.     

顶头孢霉遗传育种研究进展

顶头孢霉是一类重要的工业微生物,其发酵产物头孢菌素C可用来生产7-ACA,而后者是临床常用抗感染药物头孢类抗生素的重要中间体。头孢菌素C的发酵水平决定了其下游头孢类抗生素的生产水平、产品质量及价格,因此对顶头孢霉的菌种选育工作显得尤其迫切。随着分子生物学的发展,基因工程分子改造在遗传育种领域发挥着越来越重要的作用。文章综述了对头孢菌素C的生物合成以及调控的研究进展,并将国内外对顶头孢霉进行遗传育种的结果进行了归纳总结,提出了可以从提高头孢菌素C发酵水平、延伸代谢途径等不同方面对头孢菌素C生物合成及调控基因,包括外源基因的导入和表达进行改造优化,并对进一步的研究目标进行了展望,认为可以结合比较蛋白质组和基因组改组使遗传育种所获得的工程菌尽快进入产业化。     

Strain improvement and metabolic flux analysis in the wild-type and a mutant Lactobacillus lactis strain for L(+)-lactic acid production

The effects of initial glucose concentration and calcium lactate concentration on the lactic acid production by the parent strain, Lactobacillus lactis BME5-18, were studied. The results of the experiments indicated that glucose and lactate repressed the cell growth and the lactic acid production by Lactobacillus lactis BME5-18. A L(+)-lactic acid overproducing strain, Lactobacillus lactis BME5-18M, was screened by mutagenizing the parent strain with ultraviolet (UV) light irradiation and selecting the high glucose and lactate calcium concentration repression resistant mutant. Starting with a concentration of 100g L(-1) glucose, the mutant produced 98.6 g L(-1) lactic acid after 60 h in flasks, 73.9% higher than that of the parent strain. The L(+)-lactic acid purity was 98.1% by weight based on the amount of total lactic acid. The culture of the parent strain could not be analyzed well by conventional metabolic flux analysis techniques, since some pyruvate were accumulated intracellularly. Therefore, a revised flux analysis method was proposed by introducing intracellular pyruvate pool. Further studies demonstrate that there is a high level of NADH oxidase activity (12.11 mmol mg(-1) min(-1)) in the parent strain. The molecular mechanisms of the strain improvement were proposed, i.e., the high level of NADH oxidase activity was eliminated and the uptake rate of glucose was increased from 82.1 C-mmol (g DW h)(-1) to 98.9 C-mmol (g DW h)(-1) by mutagenizing the parent strain with UV, and therefore the mutant strain converts mostly pyruvate to lactic acid with a higher productivity (1.76 g L(-1) h(-1)) than the parent strain (0.95 g L(-1) h(-1)).